berberine has been researched along with Anxiety in 7 studies
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Psoriasis is a common inflammatory skin disorder, which can be associated with psychological disorders, such as anxiety and depression." | 5.72 | Coptisine Alleviates Imiquimod-Induced Psoriasis-like Skin Lesions and Anxiety-like Behavior in Mice. ( Choi, MJ; Nguyen, LTH; Shin, HM; Yang, IJ, 2022) |
| "Berberine (BBR) has shown efficacy in the treatment of diseases such as postmenopausal osteoporosis, obesity, and type 2 diabetes through regulating the gut microbiota." | 5.62 | Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota. ( Duan, L; Fang, Y; He, M; Jia, Q; Ma, S; Song, L; Sun, Q; Wang, Y; Zhang, J; Zhu, S, 2021) |
| "The present study aimed to investigate the effects of berberine (BRB) on spatial and learning memory, anxiety, acetylcholinesterase activity and cell death in an experimental model of intracerebroventricular streptozotocin (ICV-STZ) induced sporadic Alzheimer's-like dementia." | 3.83 | Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer's-like dementia: Involvement of acetylcholinesterase and cell death. ( Abdalla, FH; Adefegha, SA; Baldissarelli, J; da Silva Bernardi, J; de Andrade, CM; de Oliveira, JS; Dornelles, GL; Lenz, LS; Magni, LP; Palma, TV; Pillat, MM; Rubin, MA; Signor, C, 2016) |
| "Psoriasis is a common inflammatory skin disorder, which can be associated with psychological disorders, such as anxiety and depression." | 1.72 | Coptisine Alleviates Imiquimod-Induced Psoriasis-like Skin Lesions and Anxiety-like Behavior in Mice. ( Choi, MJ; Nguyen, LTH; Shin, HM; Yang, IJ, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Nguyen, LTH | 1 |
| Choi, MJ | 1 |
| Shin, HM | 1 |
| Yang, IJ | 1 |
| Fang, Y | 1 |
| Zhang, J | 2 |
| Zhu, S | 1 |
| He, M | 1 |
| Ma, S | 1 |
| Jia, Q | 1 |
| Sun, Q | 1 |
| Song, L | 1 |
| Wang, Y | 1 |
| Duan, L | 1 |
| Alavijeh, MM | 1 |
| Vaezi, G | 1 |
| Khaksari, M | 1 |
| Hojati, V | 1 |
| Vaziri, Z | 1 |
| Abbassian, H | 1 |
| Sheibani, V | 1 |
| Haghani, M | 1 |
| Nazeri, M | 1 |
| Aghaei, I | 1 |
| Shabani, M | 1 |
| de Oliveira, JS | 1 |
| Abdalla, FH | 1 |
| Dornelles, GL | 1 |
| Adefegha, SA | 1 |
| Palma, TV | 1 |
| Signor, C | 1 |
| da Silva Bernardi, J | 1 |
| Baldissarelli, J | 1 |
| Lenz, LS | 1 |
| Magni, LP | 1 |
| Rubin, MA | 1 |
| Pillat, MM | 1 |
| de Andrade, CM | 1 |
| Mi, G | 1 |
| Liu, S | 1 |
| Liang, H | 1 |
| Gao, Y | 1 |
| Li, N | 1 |
| Yu, B | 1 |
| Yang, H | 1 |
| Yang, Z | 1 |
| Peng, WH | 1 |
| Wu, CR | 1 |
| Chen, CS | 1 |
| Chen, CF | 1 |
| Leu, ZC | 1 |
| Hsieh, MT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-blind, Randomized, Placebo-controlled Trial of Berberine as an Adjuvant to Treat Antipsychotic-induced Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders[NCT02983188] | Phase 2/Phase 3 | 113 participants (Actual) | Interventional | 2018-04-25 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for berberine and Anxiety
| Article | Year |
|---|---|
Coptisine Alleviates Imiquimod-Induced Psoriasis-like Skin Lesions and Anxiety-like Behavior in Mice.
Topics: Animals; Anxiety; Behavior, Animal; Berberine; Imiquimod; Male; Mice; Mice, Inbred BALB C; Psoriasis | 2022 |
Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota.
Topics: Animals; Anxiety; Berberine; Equol; Fecal Microbiota Transplantation; Female; Gastrointestinal Micro | 2021 |
Berberine hydrochloride attenuates voluntary methamphetamine consumption and anxiety-like behaviors via modulation of oxytocin receptors in methamphetamine addicted rats.
Topics: Amphetamine-Related Disorders; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Berberine; C | 2019 |
The therapeutic potential of Berberine chloride hydrate against harmaline-induced motor impairments in a rat model of tremor.
Topics: Animals; Anxiety; Berberine; Essential Tremor; Exploratory Behavior; Gait; Harmaline; Male; Motor Sk | 2015 |
Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer's-like dementia: Involvement of acetylcholinesterase and cell death.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antibiotics, Antineoplastic; Anxiety; Berberine; B | 2016 |
Levo-Tetrahydroberberrubine Produces Anxiolytic-Like Effects in Mice through the 5-HT1A Receptor.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Berberine; Male; Mice; Mice, Inbred ICR; Ra | 2017 |
Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Berberine; Buspirone; Diazepam; Dose-Response Relationship, D | 2004 |